Log in or Sign up for Free to view tailored content for your specialty!
Headache News
Spontaneous intracranial hypotension significantly affects quality of life
SAN DIEGO – Spontaneous intracranial hypotension led to significant physical, mental and quality of life impact for a cohort of those with the condition, according to a speaker at the American Headache Society Annual Scientific Meeting.
Nutrient intake lower on days with nausea or vomiting in episodic migraine
SAN DIEGO —Individuals with episodic migraine had lower nutrient intake on days with nausea or vomiting compared with days without nausea, according to a poster from the American Headache Society Annual Scientific Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Combination of vaporized THC, CBD most effective at 2 hours for acute migraine
SAN DIEGO — A vaporized combination of THC and CBD was the most efficacious of four cannabis choices for acute moderate to severe migraine at 2 hours, according to an expert at the American Headache Society Annual Scientific Meeting.
AI-based models accurately predict, show promise for expansion in headache
SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting.
Concurrent atogepant, ubrogepant safe, well-tolerated for migraine at 12 weeks
SAN DIEGO — Concurrent use of atogepant for preventive treatment of episodic migraine and ubrogepant for acute migraine treatment was safe and well-tolerated at 12 weeks, according to a study.
Most women with menstrual migraine use acute treatments only
DENVER – Most with menstrual migraine utilize only acute treatments, rather than preventive measures, to address their symptoms, according to research presented at the American Academy of Neurology annual meeting.
Zavegepant nasal spray linked to higher likelihood of pain freedom at 2 hours
DENVER — Treatment with 10 mg zavegepant nasal spray was associated with a higher likelihood of pain freedom compared with placebo at 2 hours post dose, according to a presentation at the American Academy of Neurology annual meeting.
Migraine, GI symptoms increase risk of adverse psychiatric comorbidities
DENVER — For those diagnosed with migraine, gastrointestinal issues or both, psychiatric comorbidities increase the risk of worsened physical and mental states, according to an expert at the American Academy of Neurology annual meeting.
Lidocaine injection linked to increased pain relief in youths with acute migraine
DENVER — Lidocaine injection in the occipital region for young persons with acute migraine significantly increased pain relief compared with saline injections, according to research presented at the American Academy of Neurology annual meeting.
VIDEO: Climate change, brain health inextricably linked
DENVER — A panel of four experts discussed different aspects of the ways brain health and climate change are linked at the American Academy of Neurology annual meeting.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read